Hazard-based chemical screening is helping engineers get ahead of PFAS regulation before it forces a costly product redesign
There is a familiar pattern in product development that engineers know all too well. A material or part gets approved and added to a specification. It performs well. It passes every regulatory screen on the books. The product ships. It is reused in more designs. Then, two years later, a substance in that formulation ends up on a restricted list. Suddenly, the engineering team is back at the drawing board, under real pressure, reverse-engineering decisions that were made when no one had reason to question them.
This form, fit, and function cycle is not an engineering failure. It is a failure of strategy and infrastructure. With PFAS, the speed and velocity of these failures are accelerating to unprecedented levels.
The PFAS regulation wave is already here, but is far from over
Per- and polyfluoroalkyl substances (PFAS) represent one of the most complex regulatory challenges manufacturers have faced in decades. The class encompasses thousands of individual chemicals, many of which have been used in everything from surface coatings and lubricants to adhesives, inks, and processing aids that touch hardware across every stage of production. Most cannot comprehend how frequently they encounter PFAS on a daily basis.
Regulation is not theoretical. The U.S. Environmental Protection Agency has set enforceable drinking water limits for multiple PFAS compounds. The European Chemicals Agency has proposed one of the broadest-ever universal restrictions on PFAS under REACH. Individual states, including Maine, California, and Minnesota, are advancing product disclosure and phase-out requirements of their own. The EU’s proposed restriction alone covers roughly 10,000 substances. For manufacturers with global supply chains, this is not a matter of monitoring one jurisdiction. It is a moving target across dozens.
The challenge is compounded by the nature of PFAS itself. These substances appear at trace levels, often buried deep in supply chains: in a surface treatment applied by a sub-tier supplier, in a processing chemical that never shows up in a finished material declaration, in a component sourced from a region with different disclosure norms. Traditional compliance programmes, built on restricted substances lists and reactive monitoring, were not designed to manage this kind of distributed risk allocated across tens of thousands of substances.
The hard reality for engineers is this: by the time a PFAS compound appears on a restricted list in a jurisdiction that affects your product, your design decisions are already locked in.
Redesign has become a data problem
When a substance is restricted after a product has shipped or is mid-development, the remediation costs are high. Teams have to trace exactly where the substance appears, which is not straightforward when bill-of-materials data is fragmented across suppliers and ERP systems. They have to identify alternative materials and evaluate whether those alternatives will perform. They have to manage supplier transitions, re-validate, and may have to requalify with customers. Throughout all of this, timelines slip, revenue is impacted, and engineering capacity gets consumed by a problem that was foreseeable.
The question that should be asked is not ‘how do we respond faster when a substance gets regulated?’ It is ‘why are we learning about hazardous substances at the point of regulation rather than the point of design?’
The answer, in most organisations, comes back to missing systems and data. Specifically, there is a gap between the chemical information that exists in scientific hazard assessments, in global databases, in toxicological literature, and the chemical information that is actually visible to the engineers and materials teams making product decisions. Succinctly, an engineer cannot solve a problem they don’t know exists.
Hazard science precedes regulation. Long before a substance appears on a restricted list, the underlying health and environmental hazard profile has typically been characterised in the research community. The regulatory process lags years behind science. Organisations that tap into credible hazard intelligence earlier and connect it directly to their product and supplier data can identify potential problem substances well in advance of regulation. A safer chemicals approach promotes finding viable alternatives before tooling has been reallocated and supplier contracts have been signed. That is the gap that proactive chemical management is designed to close.
Proactive in practice
The distinction between reactive and proactive chemical management is not philosophical. It is operational. It comes down to whether hazard intelligence is embedded in the product development workflow, or whether it lives in a separate compliance process that only gets triggered by external events.
A reactive programme asks: Does this substance appear on a list we are required to comply with, and how quickly can we update that list? A proactive programme asks: What do we know about the inherent hazard profile of this substance, and are there lower-hazard alternatives available that still meet our performance requirements?
The proactive thought process requires a different kind of data infrastructure. It requires chemical hazard assessments that evaluate substances based on intrinsic human and environmental health properties, independent of regulatory status, exposure scenarios, or jurisdictional thresholds.
It requires those assessments to be standardised, scientifically credible, and independently reviewed so that teams can make comparisons across candidate materials with confidence. It also requires hazard data to be connected to structured product and supplier data, so that it is visible in the workflows where materials decisions are actually made, not sitting in a separate database that nobody checks during design reviews.
This is where organisations investing in hazard-based chemical management have found real advantage. When a materials engineer can see a hazard profile alongside a material specification, when a compliance team can trace a substance of potential concern through a design bill of materials before a product is finalised, the entire dynamic shifts. The question of chemical risk gets asked earlier, when the cost of course-correcting is low rather than high.
For PFAS specifically, this matters enormously. Many PFAS substances that are not yet regulated are nonetheless well-characterised in terms of their hazard profiles. Their persistence, bioaccumulation potential, and toxicological endpoints are known. An organisation with access to credible hazard intelligence on these substances can begin evaluating alternatives now, rather than waiting for the regulatory signal that will force everyone to act simultaneously and at far greater cost.
Connecting the science to the supply chain
The practical challenge is not obtaining the hazardous materials science; it exists in abundance. The challenge is connecting it to the operational systems where product decisions happen.
Most manufacturers maintain complex product structures: nested bills of materials, multi-tier supplier relationships, and factory materials databases.
These systems need to reflect not just what goes into a finished product but also how it is manufactured and at what quantity. Chemical information, when it exists at all, is often stored separately from these structures, in spreadsheets, in compliance software that sits outside the product development environment, in supplier declarations that are filed and forgotten.
Closing this gap requires integration. It means structuring chemical and material data across product hierarchies in a way that reflects how substances, components, and assemblies actually come together. It means connecting hazard intelligence and standardised assessment data with clear classification systems, directly to those product records. This integration is critical to make hazard visibility continuous rather than episodic. It means automated monitoring that flags emerging risks as regulations evolve, rather than relying on manual reviews that only happen when someone raises a concern.
It also means extending that infrastructure into supplier relationships. Much of the chemical risk in a complex product sits upstream of the OEM, in formulations and processing chemicals that suppliers may not proactively disclose because there is no current regulatory requirement to do so. Structured disclosure workflows, combined with access to shared hazard assessment resources, change the conversation with suppliers from ‘are you compliant?’ to ‘are there better options?’
This is not a trivial undertaking. It requires investment in data infrastructure and in the supplier relationships that feed it. However, the benefits of this investment are quantifiable. The cost of building this capability is substantially lower than the cost of repeated redesign cycles that will be amplified as PFAS regulation continues to expand and the window for proactive substitution narrows.
The comparison that changes the decision
One of the most underappreciated benefits of hazard-based evaluation is what it reveals about alternatives. Traditional compliance screening is binary: a substance is either restricted or it is not. That binary answer tells you nothing about whether the compliant alternatives you are considering are actually safer, or whether you are trading one future liability for another.
Hazard assessment frameworks assign standardised hazard classifications across a spectrum untethered to regulation. This data allows teams to compare candidate substances side by side on the merits of their intrinsic properties. This changes what is visible during the design process. As a result, a substance that clears every current regulatory screen can still carry a hazard profile that suggests meaningful future risk. Equally, a lower-hazard alternative that meets performance requirements can be identified and selected before the higher-hazard default becomes locked into a product design.
For PFAS alternative evaluations, this framework is valuable. The PFAS class is not monolithic. Some fluorinated compounds carry significantly different hazard profiles than others. Some non-fluorinated alternatives to PFAS functions have been well-characterised and represent genuinely lower-hazard choices; others are less well-understood and carry data gaps. Having access to rigorous, comparative hazard data, rather than simply checking whether a substance falls within the current PFAS regulatory perimeter, is what allows engineering teams to make durable decisions rather than just compliant ones.
Getting ahead of the next cycle
The PFAS regulation wave will not be the last one. The combination of advancing analytical detection capabilities, increasing regulatory ambition on chemical hazard, and growing investor and customer scrutiny of supply chain sustainability means that the pace at which substances move from ‘unregulated’ to ‘restricted’ will increase.
For engineers and product leaders, the cost of a reactive approach will be compounded over time. Each redesign cycle consumes capacity, compresses timelines, and erodes margins. Reactivity produces outcomes that are momentarily compliant rather than genuinely better. Decisions made under time pressure, with limited visibility into alternatives, rarely result in the selection of better-quality materials that proactive evaluation would have enabled.
The organisations that will navigate this landscape most effectively are those that treat chemical hazard management as a design input rather than a compliance output. Building the data infrastructure to connect credible hazard science to real product and supplier decisions enables better decision-making. It means establishing supplier relationships and disclosure workflows that surface chemical information earlier and more completely. It means embedding hazard-based evaluation into the design process at the point where it can actually influence outcomes, before performance specifications are locked, before tooling is committed, before the cost of changing direction becomes prohibitive.
The regulatory landscape around PFAS will continue to evolve. The question is whether you are going to learn about the next wave at the design stage or at the redesign stage. The difference in cost and in the quality of outcomes is substantial.
This is not a future-state problem waiting for future-state solutions. Source Intelligence and ChemFORWARD have built the application to make this model operational today. ChemFORWARD’s Chemical Hazard Data Trust provides independently developed, peer-reviewed hazard assessments that classify substances across a standardised spectrum of human and environmental health hazards, giving teams the scientific foundation to compare materials beyond regulatory status alone.
Source Intelligence’s C-Map platform connects that hazard intelligence directly to product and supplier data, embedding it into bill-of-materials workflows so that engineers and compliance teams can evaluate chemical risk in the PLM and ERP systems where they make design decisions. For manufacturers ready to stop reacting and start designing ahead of regulation, the capability exists. The question is not if, but what event will trigger you to use it.
Please Note: This is a Commercial Profile
